TLSI
BEARISHAt a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
AI-powered fundamental assessment
Key Strengths
Key Risks
Performance Snowflake
Multi-dimensional analysis across 5 key categories
P/B of -6.79 indicates the company owes more than it owns.
- Negative Price/Book ratio
- No Graham Number available due to negative earnings
Growth is present but not translating to bottom-line stability.
- Strong revenue growth (59.8%)
- High gross margins
- Lack of clear path to profitability
- High burn rate
Long-term trend is aggressively bearish.
- Recent 1-month recovery
- 5-year return of -53.2%
- Consistent earnings misses
Deterministic health scores are in the 'Weak' category.
- Current ratio of 2.80
- Piotroski F-Score 1/9
- Negative ROA (-56.8%)
Dividend strength is 0/100.
- No dividend paid
- No capacity for dividends
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for TLSI and closest competitors.
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
TLSI
TriSalus Life Sciences, Inc.
Primary
|
-53.2% | -55.4% | -18.3% | -12.9% | +17.1% | +5.8% |
|
SENS
Senseonics Holdings, Inc.
Peer
|
-81.7% | -46.7% | -43.6% | -17.0% | +6.8% | +1.4% |
|
SLP
Simulations Plus, Inc.
Peer
|
-76.6% | -65.8% | -56.0% | -6.7% | +23.6% | +10.2% |
|
SY
So-Young International Inc.
Peer
|
-65.4% | +13.5% | +262.5% | -7.9% | 0.0% | +7.8% |
|
ANL
Adlai Nortye Ltd.
Peer
|
-47.0% | -47.0% | +247.2% | +345.4% | -14.4% | -10.8% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability
Profit margins and return metrics
Growth
Revenue and earnings growth rates
Financial Health
Balance sheet strength and liquidity metrics
Financial Statement Flow
Interactive flow visualization showing how money moves through the company Q4 2025
Quarterly Earnings History
EPS performance vs analyst estimates
Healthcare Sector Comparison
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
TLSI
TriSalus Life Sciences, Inc.
|
BEARISH | $282.51M | - | -% | -86.9% | $4.6 | |
|
SENS
Senseonics Holdings, Inc.
|
BEARISH | $283.01M | - | -168.3% | -196.0% | $6.77 | Compare |
|
SLP
Simulations Plus, Inc.
|
BEARISH | $290.35M | - | -38.8% | -78.0% | $14.37 | Compare |
|
SY
So-Young International Inc.
|
BEARISH | $290.63M | - | -13.6% | -15.9% | $2.9 | Compare |
|
ANL
Adlai Nortye Ltd.
|
BEARISH | $293.36M | - | -139.0% | -% | $7.95 | Compare |
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-17 | SZELA MARY T. | Chief Executive Officer | Sale | 20,302 | $79,383 |
| 2026-03-16 | MARSHAK RICHARD | Officer | Sale | 3,457 | $14,210 |
| 2026-03-16 | COX BRYAN F | Officer | Sale | 3,184 | $13,085 |
| 2026-03-16 | DEVLIN JODI | Officer | Sale | 3,207 | $13,171 |
| 2026-03-16 | STEVENS JENNIFER | Officer | Sale | 3,530 | $14,509 |
| 2026-02-23 | VALLE WILLIAM J. | Director | Purchase | 30,487 | $166,154 |
| 2026-02-23 | STANSKY MICHAEL P. CPA | Director | Purchase | 361,098 | $1,967,984 |
| 2026-02-23 | SZELA MARY T. | Chief Executive Officer | Purchase | 30,487 | $166,154 |
| 2026-02-23 | GORDON GARY B | Director | Purchase | 9,756 | $53,170 |
| 2026-02-23 | PATIENCE DAVID | Chief Financial Officer | Purchase | 3,657 | $19,931 |
| 2025-11-24 | MARSHAK RICHARD | Officer | Stock Award | 60,000 | - |
| 2025-11-24 | COX BRYAN F | Officer | Stock Award | 40,000 | - |
| 2025-11-24 | DEVLIN JODI | Officer | Stock Award | 50,000 | - |
| 2025-11-24 | SZELA MARY T. | Chief Executive Officer | Stock Award | 550,000 | - |
| 2025-11-24 | PATIENCE DAVID | Chief Financial Officer | Stock Award | 65,000 | - |
SEC Filings
Recent regulatory filings from the SEC EDGAR database
TLSI filed its annual 10-K on March 5, 2026, providing comprehensive disclosures regarding its business operations and financial condition. While specific financial metrics and risk details were not provided in the excerpts, the filing includes dedicated sections for Management's Discussion and Analysis and Risk Factors.
Wall Street Analysts
Professional analyst ratings and price targets
Past News Coverage
Recent headlines mentioning TLSI from our newsroom.